ClinicalTrials.gg
Not yet recruitingNCT06107127Updated Oct 30, 2023

STOP - START With Rotator Cuff-related Shoulder Pain (RCRSP) Study

An interventional study of STOP in Musculoskeletal Diseases, sponsored by Sussex Community NHS Foundation Trust. Not yet recruiting. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2023-10-30.

Sponsored by Sussex Community NHS Foundation Trust · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
110
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
All
01

Study summary

Shoulder pain is the third most common type of musculoskeletal (MSK) disorder for which people seek medical care. Roughly 70% of all shoulder pain can be accounted for by one condition, namely rotator ruff-related shoulder pain (RCRSP). Despite limited research it is thought that a lack of pain-free force production of certain shoulder muscles is a key finding in those with RCRSP. Strengthening exercise appears to be an important treatment for RCRSP. However, there remains uncertainty regarding the optimal choice of exercise. It has been suggested essential to target the rotator cuff muscles. Despite this claim, exercise specific to these muscles has not been compared to exercise that specifically avoids significant rotator cuff recruitment. A clearer understanding could result in more effective treatment, and improved exercise adherence.

Key questions that this research aims to answer are:

  1. Is it important to measure pain-free force when treating people with RCRSP?
  2. Is it more effective to target the rotator cuff muscles than not when using exercise to treat RCRSP? To attempt to answer these questions this study will be split into two trials. Patients referred to Sussex Community NHS Foundation trust for treatment of RCRSP will be screened by a Physiotherapist for eligibility and those interested will be asked to give consent to participate. Trial 1 will involve participants attending a one-off 45-minute assessment. Data collection will run over a 6-month period. Participants in Trial 2 will be required to attend a minimum of 10 (or maximum of 12) 45-minute exercise sessions over a 12-16-week period. Trail 2 will last approximately 18 months, with outcomes being recorded when participants finish their exercise sessions and at 6 and 12 months after the date they started the trial.
Read the detailed description

The aims of this study are to

  1. investigate the relationship between pain-free shoulder abduction and external rotation force and pain and disability in those with RCRSP, and
  2. to assess the effectiveness of two different forms of exercise aimed at reducing pain and disability in patients with RCRSP.

The key questions that this research aims to answer are:

  1. Is pain-free shoulder force testing in patients with RCRSP using portable hand-held dynamometer reliable?
  2. Do reductions in pain-free force using this method correlate with severity of shoulder pain and disability?
  3. When treating RCRSP using resistance training (RT) exercise to specifically target the rotator cuff is compared to resistance training designed to avoid a significant contribution from these muscles, are there differences in outcome?
  4. What factors might mediate the changes in outcome in these two groups? The design is a randomised controlled trial. Trial 1 Participants will be allocated to one of two groups. Group one will be allocated researcher no. one and group two will be allocated to researcher no. two. Relevant tests will then be carried out. The two groups will then swap researcher and be tested again. The test: Using their symptomatic arm participants will be asked to push against a fixed force dynamometer (hand held force gauge), starting with a low level of effort and gradually increasing their effort stopping either at the point that they start to feel pain or when they feel they have pushed as forcefully as they can. Participants will be advised to rest for 1 minute before repeating this process a total of three times. All three measures will be recorded, and a mean will be calculated. The same procedure will then be carried out on their asymptomatic shoulders. A ten-minute break will follow, and the process will be repeated with the second assessor. This ensures that the order in which patients are assessed cannot influence the results. Once measured, the difference in pain-free force between symptomatic and asymptomatic shoulders will be described in terms of an index (a score reported as a percentage). Outcome measures will be taken once the session is over. Pain-free shoulder force index. Shoulder pain and disability index. Trial 2 Participants will be allocated in to one of the two exercise programme intervention groups. Participants will be asked to complete a minimum of ten sessions of exercise over a sixteen week period from when they start.

Group 1 - Participants will perform resistance exercises that involve pushing against a weighted pulley machine.

Exercise intensity will be progressed over each session as participants become accustomed to the stimulus involved.

Group 2 - Participants will perform resistance exercises that involve pulling against a weighted pulley machine.

Exercise intensity will be progressed over each session as participants become accustomed to the stimulus involved. Outcome measures will be taken once all sessions have been completed, and at 6 and 12 months.

Outcome measures are: Shoulder pain and disability index. Pain-free shoulder force index (if considered reliable during Trial 1).

02

Conditions studied

  • Musculoskeletal Diseases

Keywords

  • rotator cuff
03

In context

Musculoskeletal Diseases

753 studies on the registry are indexed under Musculoskeletal Diseases; 164 are open to participants now.

This study's planned enrollment of 110 is above the median of 76 across 519 interventional studies indexed under Musculoskeletal Diseases.

Browse Musculoskeletal Diseases studies →

Lead sponsor

Sussex Community NHS Foundation Trust is the lead sponsor of 7 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • Age 18 years or older

      • Shoulder pain of at least 3-month duration.
      • Minimal resting pain
      • Pain reproduced during resisted testing in shoulder abduction and/or external rotation.
      • Diagnosis of rotator cuff-related shoulder pain (RCRSP) suggested by at least 3 of the following tests being positive:

        1. Near normal passive range of shoulder flexion / abduction / external rotation
        2. Pain may or may not be present during active shoulder external rotation when tested at 0° of shoulder abduction but will increase with resisted* external rotation.
        3. Pain may or may not be present during active shoulder external rotation when tested at 90° of shoulder abduction but will increase with resisted external rotation.
        4. Pain may or may not be present during active shoulder abduction when tested through range but will increase with resisted abduction (plane of scapula, elbow extended, forearm in mid prone) at 45° and / or 90° and / or 150° and / or end-range.
        5. Pain may or may not be present during active shoulder flexion when tested through range but will increase with resisted flexion (elbow extended, forearm in mid prone) at 45° and / or 90° and / or 150° and / or end-range.
        6. Presence of a painful arc of movement.

Exclusion criteria

Exclusion Criteria:

  • Known calcific tendinopathy, based on previous imaging.

    • Patients with clinical signs of massive rotator cuff tears as defined by presence of gross weakness of rotator cuff muscles in the absence of pain.
    • Other shoulder disorders e.g., frozen shoulder, severe osteoarthritis, fracture, acromioclavicular joint pathology, history of shoulder dislocation.
    • Shoulder external rotation less than 45 degrees or 50% of the opposite side.
    • Undergone previous shoulder surgery on same side.
    • Symptomatic cervical spine pathology, defined as reproduction of neck, shoulder or upper limb symptoms with active physiological cervical spine movement of any of the following movements in isolation or in combination: flexion, extensions: rotation (left and / or right), side flexion (left and / or right).
    • Presence of significant co-morbidity e.g., neurological disorders, rheumatoid arthritis, unstable diabetes, unstable blood pressure
    • Current carcinoma, TB, or
    • Unlikely to be able to perform required clinical assessment tasks.
    • Inability to understand written or spoken English language.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
110 participants (estimated)

Study arms

  • Active comparator
    Researcher 1

    Using their symptomatic arm participants will be asked to push against a fixed force dynamometer (hand held force gauge), starting with a low level of effort and gradually increasing their effort stopping either at the point that they start to feel pain or when they feel they have pushed as forcefully as they can.

    Procedure: STOP

  • Active comparator
    Researcher 2

    Using their symptomatic arm participants will be asked to push against a fixed force dynamometer (hand held force gauge), starting with a low level of effort and gradually increasing their effort stopping either at the point that they start to feel pain or when they feel they have pushed as forcefully as they can.

    Procedure: STOP

Interventions

  • ProcedureSTOP

    Using their symptomatic arm participants will be asked to push against a fixed force dynamometer (hand held force gauge), starting with a low level of effort and gradually increasing their effort stopping either at the point that they start to feel pain or when they feel they have pushed as forcefully as they can.

06

What researchers measure

Primary outcomes

  1. Shoulder pain and disability index

    The SPADI contains 13 items that assess two domains; a 5-item subscale that measures pain and an 8-item subscale that measures disability.

    Time frame: 10 to 12 weeks

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2024; primary completion for Oct 2027, 45 months later.

Of 251 non-industry interventional studies with no phase under Musculoskeletal Diseases, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 38. This study's planned 45 months is above that.

Counting every sponsor, half of 266 studies reached it within 16 months; a quarter within 6 and three quarters within 36.

Musculoskeletal Diseases covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 24, 2023
First posted
Oct 30, 2023
StartEst.
Jan 2024
Primary completionEst.
Oct 2027
CompletionEst.
Oct 2027
Last update
Oct 30, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 30, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06107127
Lead sponsor
Sussex Community NHS Foundation Trust
Responsible party
Sponsor
First posted
Oct 30, 2023
Start date
Jan 2024 (estimated)
Primary completion
Oct 2027 (estimated)
Completion
Oct 2027 (estimated)
Last update
Oct 30, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion